Cencora Alliance Healthcare stand at The Pharmacy Show (UK)

The Pharmacy Show, the UK's largest trade show and education conference for the community and primary care pharmacy sector, once again brought the industry together in a vibrant celebration of innovation, learning, and collaboration.

Cencora team members proudly secured stand G35 with a vibrant Cencora Alliance Healthcare stand this year. The event saw over 8,500 healthcare and pharmacy professionals in attendance. With 300 exhibitors and more than 150 educational sessions led by over 200 speakers, it was a hub of ideas and insights designed to shape the future of pharmacy.

For Cencora, this year’s Pharmacy Show was particularly special. It marked our first time exhibiting in 12 years and served as the perfect stage to unveil our fresh branding. Our new identity—Cencora—represents our unwavering commitment to keeping the patient at the centre of everything we do, with ‘Cen’ symbolising the centre and ‘cora’ representing the heart. Our stand embodied this evolution, showcasing our expanded services and dedication to empowering pharmacy professionals. 

As part of our return, we proudly sponsored the Pharmacy Owners Forum, a cornerstone of the event that provided invaluable guidance on key topics such as revenue generation, expanding private services, and practical business advice. The forum also explored blueprints for business expansion, administrative and legal essentials, advertising strategies, weight management services, and understanding the rights and obligations of pharmacy owners. These sessions were designed to arm attendees with the tools and knowledge they need to grow their businesses and thrive in an ever-changing industry.

Among the many highlights, Mandeep Mudhar, Head of Alphega Pharmacy (UK) led a session on “The Importance of Creating Efficiencies and Headroom in Your Pharmacy”. His talk resonated deeply with attendees, offering actionable strategies to streamline operations and create space for growth in a demanding healthcare landscape.

Over the course of the two-day event, we engaged with an incredible number of visitors, capturing over 195 pieces of feedback and hot leads. It was inspiring to see so many healthcare professionals stopping by our stand to share how much they enjoy working with us and to discuss how we can continue to support them in delivering exceptional care to their patients. 

The Pharmacy Show was not just an event - it was a moment of transformation, connection, and inspiration. For Cencora, it reaffirmed our mission and strengthened our resolve to be a trusted partner for the pharmacy community. As we look to the future, we are more committed than ever to driving innovation, supporting growth, and keeping the heart of healthcare - our patients -at the centre of all we do.

Class 2 recall- Compound Sodium Lactate Solution for Infusion BP (Hartmann's Solution for infusion) in Viaflo 1000ml

Baxter Healthcare is recalling one batch of Compound Sodium Lactate (Hartmann’s Solution) 1000mL. This is due to a packaging error where some cartons labelled as Hartmann’s Solution may contain Ringer’s Solution 1000mL.

MHRA drug alert linkhttps://www.gov.uk/drug-device-alerts/class-2-medicines-recall-baxter-healthcare-limited-compound-sodium-lactate-solution-for-infusion-bp-hartmanns-solution-for-infusion-in-viaflo-1000ml-el-25-a-slash-46?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=4134130c-5221-48d2-8fe8-bc296bb64f23&utm_content=immediately

MHRA drug alert date 28/10/25

Further Information

For all medical information enquiries and information on this product, please email Medinfo_UKI@baxter.com, or telephone 0800 0260514. 

For stock control enquiries please email victoria_franklin@baxter.com, or telephone +44 07825 374866. 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution

Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-healthcare-ltd-ipratropium-bromide-500-microgram-slash-2ml-nebuliser-solution-el-25-a-slash-45?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=3205dad9-9795-48a8-bfca-a50aae5041c2&utm_content=immediately

MHRA drug alert date 23/10/25

Further Information

For all medical information enquiries and information on this product, please email Accord-UK Medical Information Department medinfo@accord-healthcare.com, or telephone 01271 385257.

For stock control enquiries please email Accord-UK Customer Services Team customerservices@accord-healthcare.com, or telephone 0800 373573.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use- Relonchem Ltd, Various Products

Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone tablets in error.

MHRA drug alert date 23/10/25

MHRA drug alert link: Class 4 Medicines Defect Notification: Relonchem Ltd, Various Products, EL(25)A/44 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries and information on this product, please email medicalinformation@relonchem.com, or telephone 0151 556 1860.

For stock control enquiries please email medicalinformation@relonchem.com, or telephone 0151 556 1860.

Cencora Alliance Healthcare – Wholesaler of the Year Award by Pharmacy Business

Pharmacy Business – the voice of community pharmacy, announced Cencora Alliance Healthcare the inaugural winner of the Wholesaler of the Year Award (2025).

The Pharmacy Business Awards, celebrating 25 years of excellence took place on Friday 3 October, at the Park Plaza Westminster Bridge, London. The evening, enjoyed by hundreds of talented healthcare professionals, celebrated the very best in community pharmacy, as well as recognising organisations that support healthcare in the UK.

Paula Sutherland, Sales Director, Cencora Alliance Healthcare took to the stage on behalf of the business to receive the award, presented by Kalpesh and Shailesh Ramniklal Solanki, Group Managing Editor and Executive Editor, Pharmacy Business.

Reflecting on the award, Marie Evans, Managing Director and SVP said: "This is a wonderful recognition of all the teams hard work and commitment. This award from the pharmacy industry demonstrates our progress in listening to our customers to deliver the service that they deserve.”

Paula soon returned to the stage to present the Enterprise Award, sponsored by Cencora Alliance Healthcare, recognising the pharmacy with the most enterprising venture in any area of pharmacy.

The winner was Muhammad Shuaib of Biddulph Pharmacy: Innovation and thinking outside the box are the winner’s forte, which they demonstrated by identifying local healthcare gaps and developing practical, innovative solutions. When the nearby town had no Sunday pharmacy provision despite a minor injuries unit and out-of-hours prescribing, he partnered with a taxi firm to run a free shuttle service.

Congratulations to all the award winners on the night.

Cencora Alliance Healthcare Returns to The Pharmacy Show 2025 as Sponsor of The Pharmacy Owners Forum

We are excited to announce that Cencora Alliance Healthcare will be attending the Pharmacy Show 2025 as the official sponsor of The Pharmacy Owners Forum - a new, dedicated theatre designed to support and empower pharmacy owners. This partnership highlights Cencora Alliance Healthcare’s commitment to shaping the future of pharmacy and providing valuable insights to pharmacies within the sector. 

More Than Just a Wholesaler

Cencora, formerly known as Alliance Healthcare, rebranded in 2025 to adopt the name Cencora Alliance Healthcare, uniting all its healthcare services under one powerful global brand. This new rebrand represents a shift towards greater innovation, and collaboration within the pharmacy landscape. With a commitment to supporting pharmacies and healthcare professionals, Cencora Alliance Healthcare offers tailored healthcare solutions that enhance patient care. Their expansive network reaches over 110,000 points of care across 11 countries, making them an invaluable partner, backed by a wealth of expertise.

Meet Cencora Alliance Healthcare This October

Join us at Stand G35 during the Pharmacy Show 2025, where you can meet the team in person. Take this opportunity to discover how their innovative solutions are helping shape the future of pharmacy and how their rebrand to Cencora marks the next step in delivering impactful healthcare solutions. Don't miss the chance to engage with their experts.

Register Today

Secure your free two-day pass* now and start planning your visit to the Pharmacy Show.

REGISTER YOUR FREE TICKET - CLICK HERE

*Free to attend for UK-registered healthcare professionals.

Class 4 caution in use- Gemcitabine 2g/52.6ml concentrate for solution for infusion

Hikma Farmacêutica (Portugal) S.A has informed the MHRA that the Patient Information Leaflet (PIL) contained within batch CB0033 of Gemcitabine 2g/52.6ml concentrate for solution for infusion does not contain the side effects of serious skin reactions.

MHRA drug alert Date: 04/09/25

MHRA drug alert link: Class 4 Medicines Defect Notification: Hikma Farmacêutica, Gemcitabine 2g/52.6ml concentrate for solution for infusion, EL(25)A/43 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For medical information queries please telephone +351 21 960 8410, or email portugaleupharmacovigilance@hikma.com.

For all stock control enquiries please telephone +44 020 7399 2760, or email customerserviceuk@hikma.com

Field Safety notice- Medihoney products

Packaging failures were identified related to the MediHoney® Wound and Burn products

Date of recall 02/09/25

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Ipca Laboratories UK Limited, Various Products

Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.

MHRA drug alert date 27/08/25

MHRA drug alert link:Class 4 Medicines Defect Notification: Ipca Laboratories UK Limited, Various Products, EL(25)A/42 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries and information on this product, please contact via email address:pharmacovigilance@ipcauk.com or via telephone: 08003685328

For stock control enquiries please contact via telephone: +44 (0)7446 189 936.

Class 4 caution in use - Fexofenadine Hydrochloride 120mg film-coated tablets Active

Class 4 caution in use - Fexofenadine Hydrochloride 120mg film-coated tablets

Chanelle Medical Unlimited Company has informed the MHRA of an error with the European Article Number (EAN) / Global Trade Item Number (GTIN) barcode on the cartons of the above batch of Fexofenadine Hydrochloride 120mg film-coated tablets, distributed by Healthcare Pharma Limited. When scanned, the EAN/GTIN barcode identifies the product as Naratriptan 2.5mg Tablets..
 
MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-fexofenadine-hydrochloride-120mg-film-coated-tablets-chanelle-medical-unlimited-company-el-25-a-slash-41?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=6190b8e4-635d-43ca-b371-997872fb962f&utm_content=immediately

MHRA drug alert date: 21/08/25

This is a caution in use only we are not accepting stock returns
 
For all medical information enquiries and information on this product, please contact Medical Information Department chanelle@medinformation.co.uk or telephone +44 808 304 2429 (Toll free-UK).

For stock control enquiries please email David Hammond: david.hammond@healthcarepharma.co.uk. Recipients of this Medicines Recall should bring.